Mizutani H - Search Results

1

Protective role of interleukin-18 against Fas-mediated liver injury.

Yamamoto N, Murata K, Yoneda K, Fuke H, Yamaguchi Y, Ito K, Sugimoto K, Shiraki K, Yamanaka K, Mizutani H, Takei Y. Yamamoto N, et al. Among authors: mizutani h. Int J Mol Med. 2008 Jul;22(1):43-8. Int J Mol Med. 2008. PMID: 18575774

2

Enhanced production and secretion of glial cell line-derived neurotrophic factor and nerve growth factor from the skin in atopic dermatitis mouse model.

Tokime K, Katoh-Semba R, Yamanaka K, Mizoguchi A, Mizutani H. Tokime K, et al. Among authors: mizutani h. Arch Dermatol Res. 2008 Aug;300(7):343-52. doi: 10.1007/s00403-008-0856-z. Epub 2008 Apr 29. Arch Dermatol Res. 2008. PMID: 18443810

3

Mutant interleukin-4/13 signaling blockade successfully suppresses acute phase inflammation.

Nakanishi T, Yamanaka K, Kakeda M, Tsuda K, Mizutani H. Nakanishi T, et al. Among authors: mizutani h. Arch Dermatol Res. 2013 Apr;305(3):241-7. doi: 10.1007/s00403-012-1302-9. Epub 2012 Nov 21. Arch Dermatol Res. 2013. PMID: 23179586

4

"Inflammatory skin march": IL-1-mediated skin inflammation, atopic dermatitis, and psoriasis to cardiovascular events.

Yamanaka K, Mizutani H. Yamanaka K, et al. Among authors: mizutani h. J Allergy Clin Immunol. 2015 Sep;136(3):823-4. doi: 10.1016/j.jaci.2015.06.009. Epub 2015 Jul 26. J Allergy Clin Immunol. 2015. PMID: 26220527 No abstract available.

5

Administration of Ag85B showed therapeutic effects to Th2-type cytokine-mediated acute phase atopic dermatitis by inducing regulatory T cells.

Mori H, Yamanaka K, Matsuo K, Kurokawa I, Yasutomi Y, Mizutani H. Mori H, et al. Among authors: mizutani h. Arch Dermatol Res. 2009 Feb;301(2):151-7. doi: 10.1007/s00403-008-0873-y. Epub 2008 Jul 17. Arch Dermatol Res. 2009. PMID: 18633632

6

CD8+ T cell granzyme B activates keratinocyte endogenous IL-18.

Akeda T, Yamanaka K, Tsuda K, Omoto Y, Gabazza EC, Mizutani H. Akeda T, et al. Among authors: mizutani h. Arch Dermatol Res. 2014 Mar;306(2):125-30. doi: 10.1007/s00403-013-1382-1. Epub 2013 Jul 3. Arch Dermatol Res. 2014. PMID: 23820889

7

Treatment of vitiligo vulgaris with the combination therapy of topical steroid and vitamin D3 compound.

Konishi Y, Yamanaka K, Mizutani H. Konishi Y, et al. Among authors: mizutani h. Dermatol Reports. 2012 Jun 6;4(1):e8. doi: 10.4081/dr.2012.e8. eCollection 2012 Jan 2. Dermatol Reports. 2012. PMID: 25386318 Free PMC article.

8

Human mast cell chymase cleaves pro-IL-18 and generates a novel and biologically active IL-18 fragment.

Omoto Y, Tokime K, Yamanaka K, Habe K, Morioka T, Kurokawa I, Tsutsui H, Yamanishi K, Nakanishi K, Mizutani H. Omoto Y, et al. Among authors: mizutani h. J Immunol. 2006 Dec 15;177(12):8315-9. doi: 10.4049/jimmunol.177.12.8315. J Immunol. 2006. PMID: 17142727

9

Leg ulcer caused by Mycobacterium ulcerans ssp. shinshuense infection.

Kondo M, Kurokawa I, Ito Y, Yamanaka K, Yamazaki T, Mizutani H. Kondo M, et al. Among authors: mizutani h. Int J Dermatol. 2009 Dec;48(12):1330-3. doi: 10.1111/j.1365-4632.2008.04060.x. Int J Dermatol. 2009. PMID: 20415674

10

Granzyme B is a novel interleukin-18 converting enzyme.

Omoto Y, Yamanaka K, Tokime K, Kitano S, Kakeda M, Akeda T, Kurokawa I, Gabazza EC, Tsutsui H, Katayama N, Yamanishi K, Nakanishi K, Mizutani H. Omoto Y, et al. Among authors: mizutani h. J Dermatol Sci. 2010 Aug;59(2):129-35. doi: 10.1016/j.jdermsci.2010.05.004. Epub 2010 Jun 17. J Dermatol Sci. 2010. PMID: 20621450

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

799 results

Search Page

Filters